Six years ago, Dr. Michael Peluso and his team launched a first-of-its-kind long COVID tissue bank and have been working to understand the disease ever since.
Solving Long COVID: How Decades of HIV Research Paved the Way
UCSF’s rapid shift to uncover the virus’s hidden effects and seemingly unconnected symptoms put its researchers at the forefront of the field.
No “easy home runs”: Early Long COVID trials of Paxlovid and monoclonal antibodies failed, but the treatments still have potential
While three early clinical trials of these drugs – including the UCSF outSMART trial – did not find they led to health improvements for participants, further trials are getting more intentional in targeting viral persistence.
Experts Discuss Long COVID: A Guide to Understanding Infection-Associated Chronic Disease
Long COVID researchers, including LIINC Principal Investigator Dr. Michael Peluso, discuss Long COVID and other infection-associated chronic diseases as part of a special webinar hosted by Science Translational Medicine.
How Long COVID Could Lift the Fog on Neurocognitive Disorders
Dr. Michael Peluso (UCSF) and Dr. Wes Ely (Vanderbilt University) provide insights on the burden of Long COVID neurocognitive disorders and how the broadening definition of memory disorders could include Long COVID. They stress that additional funding is needed to ensure scientists have the resources needed to find answers.
Long COVID Linked to Persistent Inflammation and Viral RNA
Scientists in the United States have been scanning patients with Long COVID symptoms in a bid to assess the long-term impact of the SARS-CoV-2 virus. They’ve done it by using a special imaging technique which lights up when it sees inflammation.
COVID-19 Found in People’s Blood Months After Infection
Researchers have detected COVID-19 viral proteins in the blood of 25 percent of patients, even up to 14 months after the initial infection with SARS-CoV-2. This means that for some Long Covid patients, their symptoms could come from ongoing infection.
Trialing treatments for Long Covid, and a new organelle appears on the scene
First up on the show this week, clinical trials of new and old treatments for Long Covid. Producer Meagan Cantwell is joined by Staff Writer Jennifer Couzin-Frankel and some of her sources to discuss the difficulties of studying and treating this debilitating disease.
Lessons in Persistence: New Long COVID trials aim to clear lingering virus — and help patients in desperate need
First up on the show this week, clinical trials of new and old treatments for Long Covid. Producer Meagan Cantwell is joined by Staff Writer Jennifer Couzin-Frankel and some of her sources to discuss the difficulties of studying and treating this debilitating disease.
First Tissue Bank May Help Solve Mystery of Long COVID Misery
UC San Francisco will launch the world’s first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments. By October 2023, an […]